Descriptor English: | Benserazide | ||||||
Descriptor Spanish: |
Benserazida
| ||||||
Descriptor Portuguese: | Benserazida | ||||||
Descriptor French: | Bensérazide | ||||||
Entry term(s): |
Benzylhydrazine, Seryltrihydroxy DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide Ro 4 4602 Ro 4-4602 Ro 44602 Serazide Seryltrihydroxy Benzylhydrazine Seryltrihydroxybenzylhydrazine |
||||||
Tree number(s): |
D02.442.175 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D001545 | ||||||
Scope note: | An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antiparkinson Agents Enzyme Inhibitors Dopamine Agents |
||||||
Registry Number: | 762OS3ZEJU | ||||||
CAS Type 1 Name: | DL-Serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide | ||||||
Previous Indexing: |
Benzene (1966-1967) Benzene Derivatives (1968-1971) Benzyl Compounds (1972) Hydrazines (1966-1972) Serine (1966-1972) |
||||||
Public MeSH Note: | 91; was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1975-78 |
||||||
Online Note: | use BENSERAZIDE to search SERYLTRIHYDROXY BENZYLHYDRAZINE 1973-78 (as Prov 73-74) |
||||||
History Note: | 91(79); was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1973-78 (Prov 1973-74) |
||||||
DeCS ID: | 23953 | ||||||
Unique ID: | D001545 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1991/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2013/07/08 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Benserazide
- Preferred
Ro 4-4602
- Narrower
Concept UI |
M0002315 |
Scope note | An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone. |
Preferred term | Benserazide |
Entry term(s) |
Benzylhydrazine, Seryltrihydroxy DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide Serazide Seryltrihydroxy Benzylhydrazine Seryltrihydroxybenzylhydrazine |
Concept UI |
M0002316 |
Preferred term | Ro 4-4602 |
Entry term(s) |
Ro 4 4602 Ro 44602 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey